Related Experiment Video
Updated: Nov 2, 2025

12:14
Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
Published on: February 12, 2016
35.5K
Systematic Study of Immune Cell Diversity in ischemic postconditioning Using High-Dimensional Single-Cell Analysis
Yang Yao1, Yaning Li1, Weihua Ni1
11Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.
Aging and Disease
|June 7, 2021
Summary
Ischemic postconditioning (IPostC) protects the brain by modulating immune cells. This study reveals specific immune cell changes in the brain and blood that contribute to IPostC
Area of Science:
- Immunology
- Neuroscience
- Stroke Research
Background:
- Ischemic postconditioning (IPostC) involves cycles of reperfusion and reocclusion to treat ischemic stroke.
- Understanding the immune response is crucial for optimizing IPostC efficacy.
- Single-cell analysis provides detailed insights into immune cell function during IPostC.
Purpose of the Study:
- To identify and characterize immune cell subsets in the ischemic brain and peripheral blood after IPostC.
- To elucidate the functional roles of these immune cells at the single-cell and protein levels.
- To analyze cell surface marker intensity as an indicator of inflammation and IPostC-induced protection.
Main Methods:
- High-parametric single-cell mass cytometry was employed to analyze immune cells.
- Immune cell subsets and their functions were characterized in both ischemic brain tissue and peripheral blood.
- Analysis of cell surface marker intensity was performed to assess inflammatory states.
Main Results:
- Downregulation of 4E-BP1 and p38 in microglia and myeloid-derived cells (MoDM) within the ischemic brain was associated with IPostC-induced protection.
- In peripheral blood, downregulation of p38 in CD4 T cells and regulatory T cells (Tregs) also contributed to IPostC-induced protection.
- Specific immune cell phenotypical and functional changes were identified at the single-cell and protein levels.
Conclusions:
- IPostC-induced neuroprotection involves specific alterations in immune cell populations within the brain and periphery.
- Targeting pathways involving 4E-BP1 and p38 in microglia, MoDM, CD4 T cells, and Tregs may enhance IPostC therapy.
- This study provides a detailed single-cell and proteomic understanding of the immune response to IPostC.

